Investors Contact Payment Careers Research Request
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
  • Support
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference

Oct 17, 2017

Interpace Diagnostics Announces Increased Reimbursement for ThyGenX®

Oct 11, 2017

Interpace Diagnostics Announces Expansion into New Clinical Area with Launch of Molecular Lung Cancer Test

Sep 25, 2017

Interpace Diagnostics’ CEO Interviewed on The RedChip Money Report

Sep 21, 2017

Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Audit Committee Requirements

Sep 20, 2017

Interpace Diagnostics Announces Appointment of New Director

Sep 13, 2017

Interpace Diagnostics Announces New CPT Code for Reimbursement of Molecular Thyroid Test

Sep 11, 2017

Interpace Diagnostics Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City

Sep 7, 2017

Interpace Diagnostics to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017

Aug 31, 2017

Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Closing Bid Price

Aug 31, 2017
    • 1...
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • ...22
    © 2023 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    We Own Our Future Logo
    • Linkedin